Cannabis compounds prevented Covid infection, what's next?
Cannabis compounds prevented the virus that causes Covid-19 from penetrating healthy human cells, according to a laboratory published in the Journal of Nature Products. ![]()
![]()
![]()
New research found cannabis compounds, cannabigerolic acid (CBGA) and cannabidiolic acid (CBDA), can block the ceullar entry of COVID-19 and emerging variants from infecting human cells.
These compounds can be taken orally and have a long history of safe use in humans. They have the potential to prevent as well as treat infection by SARS-CoV-2.”
—— said Richard van Breemen, a researcher with Oregon State's Global Hemp Innovation Center.
—— said Richard van Breemen, a researcher with Oregon State's Global Hemp Innovation Center.
And the findings were published in the Journal of Natural Products on Monday. ![]()
![]()
![]()
With that in mind, let's look at some cheap cannabis stocks that are noteworthy. ![]()
![]()
![]()
$Tilray Brands(TLRY.US$ reported its financial results on Monday for the second fiscal quarter ended November 30, 2021, with net revenue of $155 million - up by around 20% year-over-year and down from $168 million in the first fiscal quarter. Net income increased to $6 million from a net loss of $89 million in the previous year quarter.
Tilray plans to build its business in the U.S. around its Manitoba Harvest hemp operations now that hemp is legal within the food industry. Tilray's CEO Simon disclosed Tilray's plans to infuse food and drinks with hemp and CBD, as an important part of its long-term strategy in the United States.
In terms of Europe, Tilray has already established a strong base in the EU – having established a distribution business in medical products that sells to 13 000 drugstores as well as two grow facilities that sell products to 20 different countries.
From Tilray's chart we can see that shares reclaimed the 10-day moving average and cleared downtrend resistance, although the stock faded hard from Monday's high. If Tilray stock can clear those marks, then the 50-day moving average and $10 level are in play.
Shares of Canada-based cannabis company $Canopy Growth(CGC.US$ have declined significantly in price over the past few months. However, given that the company has recently introduced new products, is it wise to scoop up its shares now?
CGC said on Nov. 5, 2021, that its revenue is expected to accelerate in the second half of its fiscal 2022, but that the "magnitude and pace of improvement is expected to be more modest than previously anticipated."
It postponed meeting its positive adjusted EBITDA target due to market share challenges in the Canadian recreational business and a slower-than-expected ramp-up of U.S. distribution for BioSteel.
It postponed meeting its positive adjusted EBITDA target due to market share challenges in the Canadian recreational business and a slower-than-expected ramp-up of U.S. distribution for BioSteel.
Furthermore, Piper Sandler analyst Michael Lavery has downgraded the stock's rating to 'Underweight' from 'Neutral' and lowered the price target to $7 from $11. So, its near-term prospects look bleak. ![]()
![]()
![]()
However, CGC's price is down to the level of record low, let's see if the stock could rebound to the $10 level, along with the 50-day moving average. ![]()
![]()
![]()
Apart from Tilray, $SNDL Inc(SNDL.US$ is another popular cannabis stock that has significantly underperformed the markets in the last three years. However, investors that are optimistic that U.S. federal legalization is on the horizon, may want to look at buying the dip. ![]()
![]()
![]()
In 2020 Sundial reported sales of $60.9 million which were significantly lower compared to sales of $75.9 million in 2019. The decline in top-line is expected to continue as analysts expect sales to range around $49 million in 2021. In Q3 of 2021, Sundial reported revenue of $14.36 million, an increase of over 15% compared to year-ago sales that stood at $12.86 million.
Last year, Sundial explained it will focus on the sale of high-margin cannabis products to improve its profit margins. It also entered the cannabis financing business to provide debt as well as equity capital to pot producers. While Sundial is diversifying its revenue base, it reported negative investment sales of $4.8 million which show it has reported unrealized losses in this vertical.
Further, Sundial has diluted shareholder wealth at a rapid pace over the last two years. In fact, the total number of outstanding SNDL shares has surpassed two billion, up from just 105 million at the end of Q2 of 2020. In its most recent quarter, Sundial reported an operating loss of $18.8 million.
But, the constant capital raise allowed Sundial to ensure its balance sheet is debt-free and provide it with the flexibility to make big-ticket investments in the cannabis sector. Sundial’s cash balance stood at $753 million at the end of Q3.
Source: Benzinga, Bloomberg, ZeroHedge, Stocknews
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
bullrider_21 : This is dangerous. Some people may take cannabis instead of vaccination.
BadPaint bullrider_21: It is! I’m getting stuck behind motorcades everyday going to work because people dying of the sickness. And my Towns sky is black from all the cremations. It’s just terrible.
Technical DNAOP bullrider_21: Hey bullrider21, thanks for your comment
As mentioned in this article, it’s a new research posted by the Journal of Nature Products and only some compounds of cannabis are effective for preventing COVID. And I write this for discovering some potential investment opportunities with this cannabis related news instead of advertising any cannabis products
StonkHunter : Cannabis can heal & cure everything except for heart disease.
Mr Trecherous Technical DNAOP: Great Article!!
The TRUTH is never dangerous. The TRUTH is a Lion. Let it loose and it can defend itself. Lies & propaganda need constant censorship and mass coerition to intimidate people into silence and bad decisions. Science is made to be tested, retested and retested again. Wake Up 
Mr Trecherous bullrider_21: Good thing you should just worry about yourself then
Tom Dillon Mr Trecherous: let them all die? You must be the 1 of 10 cnn viewers they have a right to chose and chose not to get vacein? the booster is bullshit money maker.
Tom Dillon BadPaint: let them all die? You must be the 1 of 10 cnn viewers they have a right to chose and chose not to get vacein? the booster is bullshit money maker.
Mr Trecherous :
Mcsnacks H Tupack Tom Dillon: Inalienable rights include the right to think for oneself, the right to life, and the right to self-defense, and they remain through every human's lifetime. These supersede governmental laws and cultural norms.
View more comments...